ATC Group: A10BD08 Metformin and vildagliptin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10BD08 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A10 Drugs used in diabetes
3 A10B Blood glucose lowering drugs, excl. insulins
4 A10BD Combinations of oral blood glucose lowering drugs
5 A10BD08 Metformin and vildagliptin

Active ingredients in A10BD08

Active Ingredient Description
Metformin and Vildagliptin

Combination of two antihyperglycaemic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: vildagliptin, a member of the islet enhancer class, and metformin hydrochloride, a member of the biguanide class.

Related product monographs

Title Information Source Document Type  
EUCREAS Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
GALVUS MET Film-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic
JALRAMET Film-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic

Medicines in this ATC group

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.